CD4 and neoplasm: Using TCR sequences to link clonally related T cells, we identified 7,183 CD8+ T cells (17.8% of total CD8+) and 145 CD4+ T cells (0.71 % of total CD4+) in the blood which were clonally related to predicted-reactive T cells in the tumor (Fig. 1B).